38 31/03/2023 2023-03-31 false false false false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2022-04-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 05160921 2022-04-01 2023-03-31 05160921 2023-03-31 05160921 2022-03-31 05160921 2021-04-01 2022-03-31 05160921 2022-03-31 05160921 bus:RegisteredOffice 2022-04-01 2023-03-31 05160921 bus:LeadAgentIfApplicable 2022-04-01 2023-03-31 05160921 bus:Director1 2022-04-01 2023-03-31 05160921 bus:Director2 2022-04-01 2023-03-31 05160921 bus:Director3 2022-04-01 2023-03-31 05160921 bus:Director4 2022-04-01 2023-03-31 05160921 core:LandBuildings core:ShortLeaseholdAssets 2022-03-31 05160921 core:PlantMachinery 2022-03-31 05160921 core:FurnitureFittingsToolsEquipment 2022-03-31 05160921 core:MotorVehicles 2022-03-31 05160921 core:LandBuildings core:ShortLeaseholdAssets 2023-03-31 05160921 core:PlantMachinery 2023-03-31 05160921 core:FurnitureFittingsToolsEquipment 2023-03-31 05160921 core:MotorVehicles 2023-03-31 05160921 core:WithinOneYear 2023-03-31 05160921 core:WithinOneYear 2022-03-31 05160921 core:AfterOneYear 2023-03-31 05160921 core:AfterOneYear 2022-03-31 05160921 core:ShareCapital 2023-03-31 05160921 core:ShareCapital 2022-03-31 05160921 core:RetainedEarningsAccumulatedLosses 2023-03-31 05160921 core:RetainedEarningsAccumulatedLosses 2022-03-31 05160921 core:LandBuildings core:ShortLeaseholdAssets 2022-04-01 2023-03-31 05160921 core:PlantMachinery 2022-04-01 2023-03-31 05160921 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 05160921 core:MotorVehicles 2022-04-01 2023-03-31 05160921 core:LandBuildings core:ShortLeaseholdAssets 2022-03-31 05160921 core:PlantMachinery 2022-03-31 05160921 core:FurnitureFittingsToolsEquipment 2022-03-31 05160921 core:MotorVehicles 2022-03-31 05160921 bus:SmallEntities 2022-04-01 2023-03-31 05160921 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 05160921 bus:FullAccounts 2022-04-01 2023-03-31 05160921 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 05160921 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31
Company registration number: 05160921
Doctor Now Limited
Unaudited filleted financial statements
31 March 2023
Doctor Now Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
Doctor Now Limited
Directors and other information
Directors Dr B P McGirr
Mrs J E McGirr
Dr R A P Angwin
Mrs B C Angwin
Company number 05160921
Registered office Little Hall Barn
Windsor End
Beaconsfield
Bucks
HP9 2JW
Accountants Pink Affinity Limited
Doctor Now Limited
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of Doctor Now Limited
Year ended 31 March 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Doctor Now Limited for the year ended 31 March 2023 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of Doctor Now Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Doctor Now Limited and state those matters that we have agreed to state to the board of directors of Doctor Now Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Doctor Now Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Doctor Now Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Doctor Now Limited. You consider that Doctor Now Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Doctor Now Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Pink Affinity Limited
3 October 2023
Doctor Now Limited
Statement of financial position
31 March 2023
2023 2022
Note £ £ £ £
Fixed assets
Tangible assets 5 573,904 510,283
_______ _______
573,904 510,283
Current assets
Stocks 36,233 34,211
Debtors 6 199,016 169,142
Cash at bank and in hand 611,608 809,588
_______ _______
846,857 1,012,941
Creditors: amounts falling due
within one year 7 ( 946,042) ( 951,429)
_______ _______
Net current (liabilities)/assets ( 99,185) 61,512
_______ _______
Total assets less current liabilities 474,719 571,795
Creditors: amounts falling due
after more than one year 8 ( 68,632) ( 122,182)
Provisions for liabilities ( 68,997) ( 60,690)
_______ _______
Net assets 337,090 388,923
_______ _______
Capital and reserves
Called up share capital 1,000 1,000
Profit and loss account 336,090 387,923
_______ _______
Shareholders funds 337,090 388,923
_______ _______
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 03 October 2023 , and are signed on behalf of the board by:
Dr B P McGirr
Director
Company registration number: 05160921
Doctor Now Limited
Notes to the financial statements
Year ended 31 March 2023
1. General information
The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is Little Hall Barn, Windsor End, Beaconsfield, Bucks, HP9 2JW.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Government grants
Government grants are recognised using the accrual model and the performance model.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Defined contribution plans
The company contributes to a stakeholder pension scheme forthe directors and the pension charge represents the amounts payabale by the company in the year.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 38 (2022: 36 ).
5. Tangible assets
Short leasehold property Plant and machinery Fixtures, fittings and equipment Motor vehicles Total
£ £ £ £ £
Cost
At 1 April 2022 286,957 92,130 571,080 5,639 955,806
Additions 64,493 13,426 65,401 - 143,320
_______ _______ _______ _______ _______
At 31 March 2023 351,450 105,556 636,481 5,639 1,099,126
_______ _______ _______ _______ _______
Depreciation
At 1 April 2022 32,093 68,558 341,735 3,137 445,523
Charge for the year 14,527 5,550 59,180 442 79,699
_______ _______ _______ _______ _______
At 31 March 2023 46,620 74,108 400,915 3,579 525,222
_______ _______ _______ _______ _______
Carrying amount
At 31 March 2023 304,830 31,448 235,566 2,060 573,904
_______ _______ _______ _______ _______
At 31 March 2022 254,864 23,572 229,345 2,502 510,283
_______ _______ _______ _______ _______
6. Debtors
2023 2022
£ £
Trade debtors 61,257 43,107
Amounts owed by group undertakings and undertakings in which the company has a participating interest 50,058 22,235
Other debtors 87,701 103,800
_______ _______
199,016 169,142
_______ _______
7. Creditors: amounts falling due within one year
2023 2022
£ £
Bank loans and overdrafts 60,000 66,450
Trade creditors 89,850 155,059
Corporation tax 77,725 92,082
Social security and other taxes 61,088 51,310
Other creditors 657,379 586,528
_______ _______
946,042 951,429
_______ _______
8. Creditors: amounts falling due after more than one year
2023 2022
£ £
Bank loans and overdrafts 68,632 122,182
_______ _______
Creditors include bank loans which are secured by a fixed and floating charge over the company's assets. The directors have also given personal guarantees for the bank loans.